CD8A and infection: Taken together, these results suggest that KCONVAC boost vaccination could induce antigen-specific CD8 T-cell levels similar to those of natural infection, which suggests sufficient protection against SARS-CoV-2 ancestral, Delta, and, to some degree, Omicron strains.